This research develops the TB/non-TB detection and drug-resistant categorization diagnosis decision support system (TB-DRC-DSS). The model is capable of detecting both TB-negative and TB-positive samples, as well as classifying drug-resistant strains and also providing treatment recommendations. The model is developed using a deep learning ensemble model with the various CNN architectures. These architectures include EfficientNetB7, mobileNetV2, and Dense-Net121. The models are heterogeneously assembled to create an effective model for TB-DRC-DSS, utilizing effective image segmentation, augmentation, and decision fusion techniques to improve the classification efficacy of the current model. The web program serves as the platform for determining if a patient is positive or negative for tuberculosis and classifying several types of drug resistance. The constructed model is evaluated and compared to current methods described in the literature. The proposed model was assessed using two datasets of chest X-ray (CXR) images collected from the references. This collection of datasets includes the Portal dataset, the Montgomery County dataset, the Shenzhen dataset, and the Kaggle dataset. Seven thousand and eight images exist across all datasets. The dataset was divided into two subsets: the training dataset (80%) and the test dataset (20%). The computational result revealed that the classification accuracy of DS-TB against DR-TB has improved by an average of 43.3% compared to other methods. The categorization between DS-TB and MDR-TB, DS-TB and XDR-TB, and MDR-TB and XDR-TB was more accurate than with other methods by an average of 28.1%, 6.2%, and 9.4%, respectively. The accuracy of the embedded multiclass model in the web application is 92.6% when evaluated with the test dataset, but 92.8% when evaluated with a random subset selected from the aggregate dataset. In conclusion, 31 medical staff members have evaluated and utilized the online application, and the final user preference score for the web application is 9.52 out of a possible 10.

One of the industries with the fastest growth rates worldwide, and notably in Thailand, is medical tourism. With connections to Cambodia and Laos, Ubon Ratchathani is located in lower northeastern Thailand, close to Vietnam and Myanmar. Therefore, there is a significant chance that this region will welcome medical travelers. High-quality medical facilities are available in Ubon Ratchathani to fulfill the needs of medical tourists. A visitor’s decision to travel to Ubon Ratchathani for medical treatment is influenced by factors other than the high-level medical facilities, such as lodging, accessibility to public transportation, and tourist attractions. The public transportation services in Ubon Ratchathani, especially the public bus system, are poorly designed and may let down visitors. The purpose of this study is to develop a smart public bus route design that will meet tourists’ demands. The concept of open innovation will be utilized to develop the model. We surveyed 400 visitors to Ubon Ratchathani. The tourists’ opinions and views of public transportation will be made public and used as an input parameter when designing bus routes. The bus route can then be constructed using the differential evolution algorithm (DE). A web-based smart public transportation system was built. In order to construct an efficient smart public bus system (SPBS), open innovation was used in the development phase. According to the computational results, the new routes using DE lead to a 5.97% reduction in travel distance when compared to the output of the more well-known genetic method. More than 98.5% of visitors are satisfied with the new routes, and once they start running, 99.5% of all respondents plan to use public transit.